Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

ATXN3 inhibits NEUROG1. 1 / 1

| 1

➶

reach

"We observed that expression of normal ATX-3 or ATX-3 exp (80Q) resulted in decreased signals of otx2 (blue staining mainly in MB area, XREF_FIG and XREF_SUPPLEMENTARY) and ngn1 (blue staining including telencephalon (TE), midbrain (MB), and hindbrain (HB) areas, XREF_SUPPLEMENTARY) in WT but not p53 mutant zebrafishes at 24 h post fertilization (hpf), with more profound reduced signals of otx2 and ngn1 in ATX-3 exp (80Q) mRNA injection groups (XREF_FIG, XREF_SUPPLEMENTARY)."

27851749

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...